The increasing interest in effective weight management has led to considerable investigation into cutting-edge treatments. Recently , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor activator , has shown promising results in medical trials, implying potential for considerab